Table 4.
Test | TNF-α | IL-1Ra | IL-6 | sIL-6R | IGF-1 | ESR | Estradiol | BMD total hip | BMD lumbar spine |
Serum TNF-α (pg/ml) | – | 0.303** | 0.108 | 0.245* | -0.258* | 0.310** | -0.263* | 0.169 | -0.132 |
Serum IL-1Ra (pg/ml) | 0.303** | – | 0.313** | 0.050 | -0.222 | 0.122 | 0.012 | 0.075 | -0.126 |
Serum IL-6 (pg/ml) | 0.108 | 0.313** | – | 0.041 | -0.061 | 0.421*** | 0.188 | 0.081 | 0.078 |
Serum sIL-6R (pg/ml) | 0.245* | 0.050 | 0.041 | – | -0.137 | 0.119 | -0.263* | -0.132 | -0.278* |
Serum IGF-1 (ng/ml) | -0.258* | -0.222 | -0.061 | -0.137 | – | -0.250* | 0.179 | 0.200 | 0.195 |
ESR (mm) | 0.310** | 0.122 | 0.421*** | 0.119 | -0.250* | – | -0.079 | -0.092 | -0.145 |
Serum estradiol (pmol/l) | -0.263* | 0.012 | 0.188 | -0.263* | 0.179 | -0.079 | – | 0.491*** | 0.483*** |
*P < 0.05, **P < 0.01, ***P < 0.001. BMD = bone mineral density; ESR = erythrocyte sedimentation rate; IGF-1 = insulin-like growth factor 1; IL-1Ra = IL-1-receptor antagonist; sIL-6R = soluble IL-6 receptor; TNF-α = tumor necrosis factor α.